What's New in Research Funding

Molecular structuresPage last updated January 23, 2019

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the C. David Naylor Building, Suite 119, 6 Queen’s Park Cres W. to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact (TBD).
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates


January 23, 2020
 

  • University of Toronto: Institutional Strategic Initiatives - Upcoming Workshops.  Institutional Strategic Initiatives (ISI) at the University of Toronto are large-scale, cross-divisional initiatives that support interdisciplinary teams of our researchers and partners to address grand challenges and pursue bold ideas that require true collaboration and the integration of various disciplinary research approaches. The institutional goal is to improve our capacity to seed, develop, implement and support such initiatives. ISI Workshops provide opportunities for researchers to come together to determine what the foundations could be for these initiatives. Over the next few weeks the following workshops have been scheduled. If you would like to receive more information about a workshop, please contact strat.initiatives@utoronto.ca including your name, academic unit, your research area and which workshop you would like to learn more about. Details on each workshop can be found here. Information on how to develop ISIs, ISI support programs, connecting with upcoming ISI workshops, and templates can be found at http://www.research.utoronto.ca/isi.
    • Beyond Therapy: Community-Engaged Arts Research Creation as a Method for Social Wellness - January 24, 2020 
    • Gender and the Economy - February 4, 2020
    • Healthcare Robotics Interdisciplinary Collaboration - February 12, 2020
    • Plastics - February 19, 2020
    • Materials Acceleration Platforms: AI/Robotics/Computation for accelerated discovery - February 20-21, 2020
    • Mental Health for Youth and Students - TBD
      .
  • 2020 NSERC Collaborative Research and Training Experience (CREATE) - Information Session. NSERC’s CREATE program awards grants of up to $1.65M over 6 years for the development of innovative training programs that enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce. Learn more about this program at our Information Session. Dr. Luis Seco, a former CREATE Committee member will give insights on the program and the application process. Remote Skype details can be found here. The session details are as follows:
    Date: Friday, February 7, 2020 from 2:30pm - 4pm
    Location: McMurrich Building, 12 Queen's Park Cres. West, Room 107
    Please RSVP by February 4th to teresa.trimboli@utoronto.ca.
     
  • Banting-CANSSI Ontario Discovery Award in Data Science. CANSSI Ontario and The Banting Research Foundation are pleased to announce two Banting-CANSSI Ontario Discovery Awards in Data Science. These new investigator awards are a one-year grant of up to $25,000 and are intended to support statistical or computational research related to a health or biomedical problem. Discovery Awards from The Banting Research Foundation support young Canadian researchers who demonstrate excellence and creativity in health and biomedical science. In keeping with the mission of CANSSI Ontario, applicants should be proposing new, innovative statistical or computational methodology, or proposing to implement existing methods in novel ways, to address a health or biomedical research question. Applications will be accepted from new investigators appointed at Ontario Universities. One of the two awards is earmarked for a University of Toronto or affiliated research institute faculty member. Application deadline: February 14, 2020.
     
  • JDRF: Discovery and Development of Strategies for Targeted Drug Delivery to Human Islets for T1D. JDRF aims to catalyze and support innovative studies for the selective delivery of therapeutics (bioactive molecules) to human beta cells, or other major pancreatic cell types, to promote the survival and recover functional beta-cell mass in type 1 diabetes (T1D). Expressions of Interest (EOI) from investigators who would be interested in collaborating with a cross-functional team to help achieve this goal are being solicited. Both validation of existing drug-delivery systems and the discovery of novel drug-delivery systems are of interest. Deadline for Letters of Intent: February 7, 2020 at 5pm ET. Full application deadline: March 20, 2020.
     
  • Ara Parseghian Medical Research Fund (APMRF): Research Grants. The goal of the APMRF is to raise funds that will support research projects to find a treatment for Niemann-Pick Type C (NPC) disease. This funding supports an international research program:
    - To expedite a treatment and cure for NPC disease
    - To promote collaborative research efforts among the world's leading experts in cholesterol metabolism, cell biology, neurobiology, genetics, pharmacology and other areas of science
    - To study similar and further the cause of other neurodegenerative diseases as well as cholesterol storage disorders.
    Research grants will provide support for up to USD $100,000; a few collaborative research grants will provide support for up to USD $250,000. Deadline for Letters of Intent: March 1, 2020; Full application deadline: May 1, 2020.
     
  • Cures Within Reach.
    • Preclinical Repurposing Research to Address Meniere's Disease.  This RFA is seeking preclinical repurposing research projects to address Meniere's disease (MD). We are interested in research testing generic or proprietary drugs, devices, nutraceuticals or diagnostics that could ultimately be repurposed in the clinic to create "new" treatments to 1) reduce the symptoms, progression or incidence for MD; 2) restore function lost to MD; or 3) to reduce or eliminate severe side effects of currently used therapies for MD, thereby improving patient outcomes and quality of life. Amount: Up to USD $50,000. Deadline for proposals: March 9, 2020.
    • Repurposing Research to Improve Clinical Patient Outcomes in Meniere's Disease. This RFA is seeking repurposed treatments to address Meniere's disease (MD). We are interested in generic or proprietary drugs, devices, nutraceuticals or diagnostics that could be repurposed to create "new" treatments to 1) reduce the symptoms, progression or incidence for MD; 2) restore function lost to MD; or 3) to reduce or eliminate severe side effects of currently used therapies for MD, thereby improving patient outcomes and quality of life. Amount: Up to USD $100,000. Deadline for proposals: March 9, 2020.
       
  • International OCD Foundation. 
    • Young Investigator Awards. The intent of these awards is to support promising young investigators who are developing their careers while pursuing creative and impactful research projects on OCD and related disorders across a range of disciplines. Only research projects that investigate topics in the field of OCD and related disorders (OCD, including pediatric OCD; PANS/PANDAS; hoarding disorder; body dysmorphic disorder) will be considered for funding. Amount: Up to USD $50,000. Deadline for proposals: March 2, 2020.
    • Breakthrough Awards. The IOCDF offers the Breakthrough Awards to senior researchers pursuing impactful projects investigating OCD. The Breakthrough Awards are intended to support innovative and potentially-groundbreaking projects – “high-risk, high reward” science that could make a profound impact on the field and accelerate progress toward new and more effective treatments for OCD, and possibly even lead to a cure. Amount: Up to USD $500,000. Deadline for proposals: March 2, 2020.

 

January 17, 2020
 

  • Tri-Agency workshops to improve online grants management systems: January 27, 2020.  CIHR, NSERC, and SSHRC are collaborating on a Tri-Agency initiative to improve the online grants management systems, with an aim to better support the needs of the Canadian research community. For more information on the Tri-Agency Grants Management Solution (TGMS) initiative, please see the TGMS one-pager
    As a part of this initiative, TGMS is engaging users early and often through targeted activities to better understand the research community’s needs. Over the past several months, TGMS has developed journey maps (user process visualizations) through consultation to represent the research community's primary users in the roles of applicants, reviewers, and research administrators. To enhance and deepen the content of the journey maps Tri-Agency is now engaging a larger group of users.

    University of Toronto researchers who have previous experience as applicants and/or reviewers for Tri-Agency granting programs are welcome to register for a consultation workshop. Your participation in this workshop would be indispensable for improving the online grant management experience, both for you and your colleagues. There are two separate workshop sessions scheduled for Monday, January 27th. You are invited to register for one of the following sessions, based on your experience in the roles of an applicant or a reviewer, by clicking on the appropriate registration link:
    APPLICANT WORKSHOP:
    Date/Time: Monday, January 27, 2020 from 9am-12pm
    Location: O.I.S.E., room 8214 (252 Bloor St. W - see campus map)
    Registration Link: https://cris.eve.utoronto.ca/home/events/528
    REVIEWER WORKSHOP:
    Date/Time: Monday, January 27, 2020 from 1pm-4pm
    Location: O.I.S.E., room 5230 (252 Bloor St. W - see campus map)
    Registration Link: https://cris.eve.utoronto.ca/home/events/529
     
  • New Frontiers in Research Fund (NFRF) Transformation WEBINARS. NFRF will be hosting webinars for applicants and research administrators at each stage.  There is a limited number of attendee spots per webinar (approximately 1000) so participants are encouraged to join webinars as a group.  Links to the webinar will be publicly available approximately one hour prior to the start time and are accessible by clicking on “Join Webinar” in the Transformation Competition program page (see “Webinars” section.) Webinars will be recorded and presentations will be available following the session.
    Date/time: Tuesday, January 21, 2020 from 10am - 12pm (ET) French
    Date/time:
    Tuesday, January 21, 2020 from 1pm - 3pm (ET) English
     
  • Connaught Global Challenge Award. $1 million annually will be awarded to support approximately 4 team initiatives of up-to $250K each.  The program aims to heighten UofT’s contribution to important issues facing society through the advancement of knowledge, and the transfer and application of solutions. Global Challenge teams will represent new collaborations involving leading UofT researchers and students from multiple disciplines, along with innovators and thought leaders from other sectors. The program objective is to enhance UofT’s capacity to achieve meaningful outcomes and impact, including but not limited to: major new external funding to further develop solutions to the global challenge, important new partnerships, and/or new research oriented academic programs.
    The competition is open to all areas of scholarship, however applications related to youth and student mental health, climate change and sustainability, research regarding the recommendations of the Truth and Reconciliation Commission, and the President’s Three Priorities are encouraged. The program is open to all full-time professorial staff (tenured or tenure-stream) at the University of Toronto.  Questions regarding eligibility can be directed to the Connaught Secretariat. Deadline for applications: February 3, 2020.
     
  • CIHR Project Grant - Spring 2020: WEBINARS. CIHR will be hosting the following webinars to support participants with the requirements of the funding opportunity “Project Grant – Spring 2020 Competition” and to answer questions on how to apply. Please download and read the presentation available on the registration page prior to the webinar.
    ENGLISH:
    Monday, January 27, 2020 from 1pm - 2pm ET. Register
    Thursday, February 17, 2020 from 3pm - 4pm ET. Register
    FRENCH:
    Monday, January 27, 2020 from 3pm - 4pm ET. Register
    Thursday, February 17, 2020 from 1pm - 2pm ET. Register
     
  • NSERC Collaborative Research & Training Experience (CREATE): INFORMATION SESSION & WEBINARS. The CREATE program supports the training of teams of outstanding students and postdoctoral fellows from Canada and abroad through the development of innovative training programs that encourage collaborative and integrative approaches, address significant scientific challenges associated to Canada's research priorities, and facilitate the transition of new researchers from trainees to productive employees in the Canadian workforce.
    This program involves a two step process.  The first step involves the submission of a Letter of Intent (LOI).  Those selected at the LOI stage will proceed to the second step and submit a full application.  Please note that there is a maximum number of LOI’s that can be submitted.  In the past, the University of Toronto has been able to submit up to 6 LOI’s.  We are waiting confirmation of our quota from NSERC.  If more than 6 LOI’s are submitted, we will conduct an internal peer review to select the top rated projects using the same evaluation criteria as NSERC. This year, the CREATE Program offers two additional opportunities within its current budget envelope. These include an Industrial Stream and an International Collaboration with Germany. Amount: $1,650,000 over 6 years. Further details and additional details about the webinar can be found here (UTOR id required).
    INFORMATION SESSION: An information session will be held by Research Services Office in early February.  Date and time will be confirmed shortly.
    WEBINARS: 
    English: February 6, 2020 from 1pm 3pm ET
    French: February 7, 2020 from 12:30pm - 2:30pm ET
    DEADLINES: If you are interested in submitting an LOI, please advise Jessica Keating (jessica.keating@utoronto.ca) by March 1, 2020 so that we can put together an internal review panel. UofT internal deadline for LOIs: Thursday March 12, 2020 (FIRM); Sponsor deadline for LOIs: May 1, 2020.
     
  • Can-GARD: Clinical and Research Fellowship in Advanced Genomics in Paediatric Rare Disease. The Canadian Gene Cure Advanced Therapies for Rare Disease (Can-GARD) project and the Centre for Genetic Medicine (CGM), with support from the Division of Clinical and Metabolic Genetics at The Hospital for Sick Children (SickKids). As an emerging area in paediatrics, this clinical research genomics fellowship offers clinicians the opportunity to pursue independent research and clinical work in partnership with a wide range of professionals to enhance children’s health and well-being. This one-year training position begins on July 13, 2020. Application deadline has been EXTENDED to February 7, 2020.
     
  • National Multiple Sclerosis Society: Research Grants.  The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation. The Society will add the indirect cost of 10% of the sum requested. Pre-application deadline: February 5, 2020; Full application deadline: February 12, 2020 at 5pm EST.
     
  • Prostate Cancer Foundation: 2020 PCF Young Investigator Awards. These awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used innovatively and flexibly to advance the career and research efforts of the awardee. This for example, includes funding “protected time” or direct costs for laboratory science. This award does not support indirect costs such as institutional overhead. Every PCF Young Investigator is required to be under the direct supervision of 1-3 mentors. Applicants may be working in basic, translational, computational or clinical research and need not be trained specifically in prostate cancer research to be highly competitive. However, successful applicants should be working in an academic research environment capable of supporting transformational prostate cancer research. Applications deadline: March 23, 2020 at 3pm.
     
  • Cancer Research Institute: CRI Irvington Postdoctoral Fellowships Program. This program furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists. CRI is seeking hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer. Amount: $175,000 over three years. Deadline for applications: April 1, 2020.
     
  • Alport Syndrome Foundation (ASF): Research Program. The principal goal of the Alport Syndrome Foundation, Inc. (ASF) is to find novel treatments to prevent kidney failure and hearing loss in all patients with Alport syndrome. Application Focus: Identification and investigation of target pathways in disease progression; Development of means to improve early-stage, definitive, and predictive diagnosis; and Repurposing of an FDA-approved drug to improve the current standard of care. Early investigators are encouraged to apply. Amount $125,000 over a one-to-two-year timeframe. Deadline for applications: February 7, 2020.
     
  • International Essential Tremor Foundation (IETF): IETF Grant Program. The IETF is requesting proposals for grants addressing the nosology, etiology, pathogenesis, treatment or other topics relevant to essential tremor. The aim of this request is to stimulate inquiry into this poorly understood clinical disorder and to provide support to projects that are innovative and give promise of receiving more substantial support from other sources. Amount: USD 25,000 for one year with the possibility of being renewed for a second year. Deadline for applications: February 28, 2020.
     
  • Batten Disease Support and Research Association (BDSRA): Annual Funding Cycle. BDSRA seeks letters of intent from the Batten and larger lysosomal disease research community for innovative technologies in biomarkers for any of the 14 forms of Batten disease. Development of, or improvement of biomarkers using tissue, blood, urine or imaging are welcome, as are new concepts in development.  Investigators from centers with a history of research in metabolic diseases are strongly encouraged to apply. Amount: USD $40,000; however exceptional applications may be funded at a higher amount if the budget request is justified. Initial grants are awarded for one year with potential of renewal based on progress made during the first year. Deadline for Letters of Intent: March 25, 2020.
     

January 8, 2020
 

  • NSERC - Next phases of Alliance grants. NSERC is pleased to announce that Alliance grants are now open for all Option 1 applications requesting more than $20,000 annually from NSERC.
    Option 2 applications requesting support for up to 90% or 100% of the costs of the project will be accepted in early 2020
    For full details about Alliance grants and how to apply, please visit the University's webage:  (UTORid required). 
    If you have any questions or comments about Alliance grants please contact Alliance@nserc-crsng.gc.ca  and sign up on the Alliance webpage to be added to the mailing list so you can stay up to date on the latest information.
    Please consult the Alliance Latest News page and the updated Frequently Asked Questions for more information on Option 2.
     
  • Crohn's & Colitis Canada: 2020 Innovations in IBD Research. The objective is to fund novel or innovative approaches to IBD research. This grant is intended to stimulate and support research which may not be encompassed within the boundaries of traditional medical research. Research proposals must conform to sound principles of research and may aim to collect pilot data for follow-on application(s). Amount: Up to $50,000 for one year. Application deadline: January 31, 2020 at 5pm.
     
  • 2020 KRESCENT Post-Doctoral Fellowships and New Investigator Award Programs. The application guidelines for these programs are available on the KRESCENT’s website and on the proposalCENTRAL website (https://proposalcentral.altum.com/) Applications in English must be completed via the on-line application system proposalCENTRAL. Please allow extra time to review the system before the application deadline of February 01, 2020. To apply through this site, you will have to set up a profile, and then search for “KRESCENT” or “Kidney” and fill out the KRESCENT application. Please note: the French version of the on-line application system is not available at this time. To apply in French, all forms and guidelines for the 2020 competition can be found on the Krescent website. Questions should be directed to christine.marquis@kidney.ca
     
  • Kidney Foundation of Canada: 2020 Allied Health Kidney Competition - Allied Health Research Grant, Doctoral Fellowship and Scholarship. Applications for the 2020 Allied Health Kidney Research Grant and Doctoral Fellowship Competition must be completed via the on-line application system proposalCENTRAL. Please allow extra time to review the system before the deadline of March 01, 2020. To apply through this site, you will have to set up a profile, and then search for “Kidney” under “Grant Opportunities” and fill out the Allied Health Kidney Research Grant or the Doctoral Fellowship application. To apply to the Allied Health Kidney Scholarship, please visit the Kidney Foundation of Canada’s website.The policies for the 2020 Allied Health Kidney Research Grant and Doctoral Fellowship are also available on The Kidney Foundation of Canada’s Website and on the proposalCENTRAL websitePlease note:  the French version of the on-line application system is not available at this time. To apply in French, all forms and policies for the 2020 competition can be found on the Kidney Foundation of Canada’s website. Questions should be directed to christine.marquis@kidney.ca.
     
  • CIFAR Azrieli Global Scholars Program 2020. This program provides unrestricted research support of $100,000 CAD, leadership training, mentorship, and opportunities for highly-promising early-career researchers in the first five years of a full-time research position to collaborate with colleagues from diverse disciplines. Applicants can be from anywhere in the world, must hold a PhD (or equivalent) and be within the first five years of a full-time academic research position (e.g. Assistant Professor level or equivalent). The Deadline for applications is February 5, 2020. Scholars' research interests must be aligned with the themes of an eligible CIFAR research program. In 2020, the eligible programs are:
  • amFAR: Target Grants. Although applicants may submit research plans exploring any area of basic or preclinical research relevant to providing the foundation for new approaches to an HIV cure, the following represent particular areas of interest: Generate preclinical models that predict clinical trial outcome; Use provirus to elicit destruction of cellular reservoir; and Characterize and manipulate reservoir cell environment. Amount: USD $200,000 (including indirect costs at a maximum rate of 20%) over two years. Deadline for registration: January 17, 2020; Deadline for Letters of Intent: Tuesday January 29, 2020. 
     
  • Savoy Foundation: Research Grants. Research grants are available to individuals working on epilepsy or related subjects. Grants are available to clinicians and/or established scientists. These grants will be for the following purposes: Launch of a project; preliminary studies; Pursuit or completion of a project: temporary support following the interruption or the termination of a grant; Contribution to the funding of a research project of particular interest in the field of epilepsy; Contribution to the funding of a scientific activity. Amount: Up to CAD 25,000. Deadline for applications: January 15, 2020.
     
  • PCS Partners Seeking a Cure: Research Grants. These grants are award to conduct research that addresses an important and novel, basic or clinical research question related to primary sclerosing cholangitis (PSC) and closely associated diseases (such as inflammatory bowel diseases (IBD) and cholangiocarcinoma). This program seeks to encourage investigators to conduct research in promising new areas, with the goal that data generated will lead to federal (NIH) or external international funding. Amount: USD $30,000 per year for two years. Deadline for applications: January 30, 2020.
     
  • FRAXA Research Foundation: FRAXA Fellowships. Each year, FRAXA funds medical research aimed at finding specific treatments and ultimately a cure for Fragile X syndrome. Their goal is to bring practical treatment into current medical practice as quickly as possible; so preference is given to projects that have a clear practical application and the results of which will be shared in a timely fashion. Any scientist is eligible for salary support from these awards (not just postdocs), and a supply budget may be included. Amount: USD $45,000 per year for two years. Deadline for applications: February 1, 2020.
     
  • Kenneth Rainin Foundation: Innovator Awards. The Foundation supports research that is potentially transformative to diagnosing, treating and curing Inflammatory Bowel Disease. The Innovator Awards program provides grants for research projects, which due to their ground-breaking nature, may not be suitable for funding from more traditional sources. Amount: USD up to $200,000, which may include up to 10% for indirect costs. Deadline for LOIs: February 18, 2020; Full proposal due: May 12, 2020.
     
  • Lady Tata Memorial Trust: International Awards for Research in Leukaemia. These awards are restricted to studies of leukaemogenic agents, and the epidemiology, pathogenesis, immunology and genetic basis of leukaemia and related diseases. Amount: Up to £35,000 for one year. On an exceptional basis, an award for a second year can be made. Priority will be given to those intending to move to other centres with a view to establishing scientific collaboration between laboratories. Deadline for applications: March 15, 2020.
     

December 11, 2019
 

  • New Frontiers in Research Fund - Transformation.  The inaugural Transformation competition of the New Frontiers in Research Fund (NFRF) program is now open.
    Transformation stream funding aims to support large-scale, Canadian-led interdisciplinary research projects with the potential to realize real and lasting change (high reward). Projects funded by Transformation Stream Grants:
    1.    tackle a well-defined problem or challenge;
    2.    propose a novel world-leading approach that’s different from current state-of-the-art approaches to the problem or challenge;
    3.    are interdisciplinary bringing different perspectives to the defined problem; and
    4.    have the potential to be transformative – meaning the potential to create a significant and real change or impact, rather than an incremental advance.
    The problem or challenge may be fundamental, leading to a scientific breakthrough, or applied, with a social, economic, environmental or health impact.
    All competition documents are available on the NFRF website.  Applicants will apply using the Convergence Portal
    Value and Duration:  Transformation grants are valued at between $2 million and $4 million annually (inclusive of indirect costs) for up to 6 years.  For this first round, $144 million is available over 6 years, enabling 6-12 projects nationally. Upcoming Webinars and how to apply and other support for applicants can be found here. Sponsor's webpage here.
    NOI - UofT internal MRA deadline: February 13, 2020; NFRF deadline for NOI: February 18, 2020.
     
  • NEW - University of Toronto: Institutional Strategic Initiatives (ISI).  The ISI portfolio is led by the Associate Vice-President and Vice-Provost, Strategic Initiatives (AVPVP SI), with a dual report to the Vice-President & Provost and the Vice-President, Research & Innovation, and Strategic Partnerships, serves as a hub for supporting these interdisciplinary and cross-divisional initiatives. The research groups they are looking to support  “are large-scale, cross-divisional initiatives that support interdisciplinary teams of University of Toronto researchers and partners to come together to address grand challenges and pursue bold ideas. The institutional goal for these initiatives is to improve our capacity to seed, develop, implement and support cross-divisional, interdisciplinary, excellence-driven initiatives.”
    A few notes to take into account;

    1.    To access the to the details and documents in the link above, you will need to use your UTORid.
    2.    There are many points where there is reference to “cross divisional” research. Please keep in mind that in this instance, the “divisions” are faculties (for example; Faculty of Medicine, Faculty of Arts and Science etc).
    3.    Please contact strat.initiatives@utoronto.ca to discuss if your Network meets their criteria to apply.

  • Pre-announcement - CIHR Team Grants: Diabetes Mechanisms and Translational Solutions.  The Team Grants will support multi-disciplinary research to better understand the underlying causes andpathophysiology of diabetes, and develop improved prevention and treatment approaches for diabetes. The total amount available at the LOI stage is $200,000, enough to fund approximately 20 LOIs ($10,000 each). At the full application stage, a total of $20,000,000 is available, enough to fund up to 10 grants. Expected launch date: Early winter.

  • Canadian Cancer Society: CCS Emerging Scholar Award. Through the CCS Emerging Scholar Award program, early career investigators will develop their cancer research programs in Canada and pursue important scientific advances of the highest quality and potential for impact. CCS is committed to supporting all areas and disciplines of cancer research and building capacity across Canada. Applications from the four pillars of health research (ie. biomedical; clinical; health services; and social, cultural, environmental and population health) are encouraged, and geographic and gender diversity will be strongly considered during the evaluation process. Deadline for Letters of Intent: February 5, 2020.
     

  • The Canadian Asthma, Allergy and Immunology Foundation (CAAIF). Deadline for Letters of Intent: January 10, 2020; Full applications (invitation only) due: March 1, 2020.
    • CAAIF Top 10 Challenge Food Allergy Research Grant. This grant is focused on food allergy research and will provide one grant of $25,000 to fund a patient-centered food allergy research grant. Preference will be given to investigators who have not received this award within the past two years.
    • CAAIF/Pediapharm Research Grant in Allergic Diseases. The objective of the CAAIF/Pediapharm Research Grant in Allergic Diseases is to fund a patient-centered food allergy research grant. The maximum value of this award is $25,000.
  • National Multiple Sclerosis Society: Research Grants. The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation. Investigators may request funds for the following categories of expenditure: salaries for professional and nonprofessional personnel, patient costs, permanent equipment, consumable supplies, travel, other expenditures not
    included under the above categories, and indirect costs. Deadline: February 12, 5:00 pm EST (pre-applications due February 5).

  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcements. For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     

  • Alzheimer's Drug Discovery Foundation (ADDF): Deadline for Letters of Intent: January 17, 2020; Full proposal due: February 7, 2020
    • Neuroimaging and CSF Biomarker Development Program. This RFP prioritizes biomarker programs that define a specific use and have potential for commercial and clinical translation, with an emphasis on clinical trials. Amount: Up to USD $600,000 - One year with potential for follow-on funding. Multi-year proposals can be considered.
    • Program to Accelerate Clinical Trials (PACT). The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer's disease and related dementias. This includes novel, repurposed, and repositioned drugs as well as natural products. Average Award: Up to USD $3,000,000 based on stage and scope of research. Multi-year. Potential for follow-on funding. 
    • Drug Development Program. This RFP focuses on building preclinical evidence in animal models and on advancing lead molecules to the clinical candidate selection stage. The proposed studies should have a high probability of reaching IND-enabling studies within two years. Average Award: Up to USD $600,000 based on stage and scope of research. One year with potential for follow-on funding. Multi-year proposals can be considered. 
    • Prevention Beyond the Pipeline. The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.  Amount: USD $50,000-$100,000 for epidemiological analyses based on scope of research; Up to USD $3 million for clinical trials based on stage and scope of research.
       
  • Friedrich's Ataxia Research Alliance (FARA): Keith Michael Andrus Cardiac Research Award. This award was made in honor of its namesake to remember Keith's legacy and to help advanced our understanding and treatment of the cardiomyopathy associated with FA. Proposals for this award should focus on advancing understanding and/or treatment of the cardiac involvement in FA. Amount - Maximum budget: USD $150,000 per year for 1 or 2 years. Deadline for Letters of Intent: January 15, 2020; Full application due: March 1, 2020.
     
  • National Psoriasis Foundation (NPF):
    • Psoriatic Disease Research Fellowships. The program provides support to eligible institutions to develop and enhance the opportunities for physicians training for research careers in academic dermatology, rheumatology, pediatric dermatology, and pediatric rheumatology. Priority consideration will be given to applications that advance psoriatic disease research. Awardees will receive a maximum of USD $50,000 to support their fellowship stipend. Deadline for applications: January 13, 2020.
    • Early Career Research Grants. The NPF is seeking grant applications from graduate students, postdoctoral researchers, and researchers at similar trainee-level positions interested in conducting projects focused on psoriatic disease. The goal of this award is to support scientists at this challenging early career stage and to welcome them into the collaborative community of scientists, clinicians, and patients involved with NPF research. Ultimately, recipients of this award are expected to be in a position to compete for future funding through NPF Discovery or Translational Research Grants and go on to establish successful long-term careers conducting
      psoriatic disease research. Amount: Up to USD $50,000 for one year. Deadline for applications: January 13, 2020.
       

November 26, 2019
 

  • Banting & Best Diabetes Centre (BBDC): Postdoctoral Fellowships 2020/2021. The BBDC will be awarding a number of postdoctoral fellowships to candidates at the post-PhD or post-MD degree stages.  The one-year fellowships normally commencing on July 1, 2020 (and no later than September 1, 2020) are for full-time research training in diabetes.  To be eligible, the candidate's proposed supervisor must be conducting diabetes research and must hold a faculty appointment with the University of Toronto at the level of Assistant, Associate, or Full Professor. The proposed supervisor is also required to be a registered member* of the BBDC at the time of application submission. Candidates must have received a doctoral degree (PhD) after July 2016, or a medical degree (MD) after July 2011 and must be within their first four years of postgraduate research training as of July 1, 2020.
    Deadline for applications: February 4, 2020.
     
  • Commercialization Grants – NSERC Idea to Innovation (I2I).  Four times per year, NSERC accepts applications for its “Idea to Innovation” (I2I) program, for the purpose of accelerating pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. All projects must be based on inventions disclosed and assigned to the University, and should be managed in conjunction with the Innovations & Partnerships Office (IPO) – the Innovations team in particular can assist with development of the Commercialization Plan, and can also assist in determining the appropriate Phase for your project. For more information please contact Hema Prabhu, Research Funding Administrator at IPO's intake email innovations.partnerships@utoronto.ca or visit NSERC's websiteUofT internal deadline: December 6, 2019; Sponsor deadline: January 6, 2020.
    .
  • The Schwartz Reisman Institute for Technology and Society is currently seeking research ideas from across the University of Toronto community. Under the leadership of Gillian Hadfield, the Schwartz Reisman Chair in Technology and Society, the Institute is currently shaping its research and programming directions. As part of this process, we want to hear your ideas about what problems, ideas, and research projects the Institute could undertake—if you’d like to work with us, we want to hear that too.

    We’re especially interested in ideas that bridge disciplines, bring together technical and non-technical communities, and approach questions about technology and society in new and different ways. Initially, we anticipate a strong focus on artificial intelligence and related technologies. However, this does not mean only, or even primarily, projects that directly engage with applications in AI and technology. We are also seeking ideas for basic research in social sciences and the humanities that can inform core challenges in technology. For example, for AI to align well with human interests and values requires developing our core theory of the nature and dynamics of human systems for determining individual and community interests and values. We are especially interested in hearing from people who are not yet working, and may not plan to work, specifically in AI and related tech fields. 
    We're holding two townhalls specifically focused on exploring research opportunities with faculty that are interested in the Institute, and hope that you'll find one of the one following dates convenient. 
    •    St. George and Scarborough Campuses (Remote participation available) - November 29th from 2:00pm - 3:30pm
    •    Mississauga Campus - December 5th from 1:00pm - 2:30pm
    Please also send any research themes, ideas, or questions to brent.barron@utoronto.ca, and if you'd like to be kept up to date on future information and opportunities from the Schwartz Reisman Institute, please subscribe.

  • Canadian Liver Foundation: CDTRP 2019 Research Innovation Competition. In partnership with the Canadian Donation and Transplantation Research Program (CDTRP), the CLF will be funding a 2019 CDTRP Research Innovation Grant specifically designated for liver donation / transplantation research. Additionally, there are up to 10 other non-organ-specific grants that are available for applications which align with one of the 5 Themes of the CDTRP. The goal of these grants is to advance long-term health outcomes and quality of life for Canadian transplant patients. 
    INFORMATION WEBINARS: December 11, 2019 at 3pm ET or January 16 at 2pm ET. Webinar link: https://cdtrp.zoom.us/j/560945514
    Deadline for applications: February 19, 2020.

  • Pediatric Oncology Group of Ontario (POGO): Seed Funding. Since 2006, POGO has offered Seed Funding Grants (of up to $15,000 each) to facilitate or support feasibility studies, self-contained studies, the development of grant applications, or projects that have the potential to generate data to inform larger studies. The subject matter of the Seed Funding Grants should either fall within one of the above-noted PRU research pillars or demonstrate relevance to the goals and objectives of POGO and the PRU. Registration deadline: December 9, 2019 at 5pm; Deadline for full applications: January 24, 2020.

  • Alliance for Cancer Gene Therapy: 2020 Investigator Award in Cell and Gene Therapy for Cancer. This award is for those conducting cell and gene therapy research in solid tumors with preference given to those researching new approaches to glioblastoma and pancreatic cancers. Candidates for this award must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty. The award provides up to a maximum of $500,000 distributed over 2-3 years, inclusive of a maximum of 10% indirect costs. Abstract deadline: December 3, 2019 at 11am (EST); Invited deadline for full applications: February 14, 2020 at 11 am (EST).

  • Lupus Research Alliance: Funding Opportunities.
    • Lupus Innovation Award.  Provides support for pioneering, high-risk, high-reward approaches to major challenges in lupus research. Amount: up to USD $150,000/year total costs for up to 2 years. Deadline for applications: January 15, 2020.
    • Lupus Mechanisms and Targets Award. Supports highly meritorious research focused on the identification and/or investigation of molecular pathways or targets that will lead to new or improved therapies for patients with lupus. Amount: up to USD $200,000/year total costs for up to three years. Deadline for applications: January 15, 2020.
    • Distinguished Innovator Award: Provides outstanding scientists with substantial support (up to USD $1 million over 4 years) to conduct highly innovative research into the fundamental causes of systemic lupus erythematosus and so provide new directions towards a cure. Deadline for Letters of Intent: March 16, 2020.
  • Leukemia Research Foundation (LRF): Hollis Brownstein New Investigator Research Grants Program. A Letter of Inquiry allows the Leukemia Research Foundation to quickly assess if there is a good match between LRF's goals and the project. If it appears to be a good match, we will request a full proposal. Deadline for Letters of Intent: February 7, 2020; Invited deadline for full applications: March 2, 2020.

  • Simons Foundation Autism Research Initiative (SFARI): Research Award. The goal of the Research Award is to provide support for investigation of key unresolved research questions in autism, particularly those that connect genetic etiologies to brain function and behavior. SFARI welcomes risk and novelty in Research Award proposals, but potential impact on the autism research field will be the most important criterion. Competitive applications will have preliminary data or other relevant groundwork that justifies substantial investment in the proposed topic. Amount: Up to USD $1,300,000, including indirect costs, over a period of up to four years. Application deadline: January 10, 2020.

  • A Foundation Building Strength (AFBS): Stronger 2020 Nemaline Myopathy Research Grant. AFBS is excited to announce a new "Stronger 2020" initiative to fund research grants, advancing our mission to find treatments and solutions for NM. AFBS has and will continue to fund research advancing our understanding of the pathogenesis and potential therapies for NM, as well as devices that support functional and quality of life improvements for NM patients and their caregivers. Each proposal can request a maximum of USD $200,000 for a two-years grant. Most proposals are expected to be in the USD $30,000 - $200,000 range. Deadline for applications: December 20, 2020.

  • Friedreich's Ataxia Research Alliance (FARA): General Research Grant. FARA supports research across the spectrum from basic research through drug development and clinical research programs in FA. FARA grant program priorities: 1. Advancing understanding of neuroscience/ systems; 2. Advancing understanding of cardiac disease in FA; 3. Advance drug discovery; 4. Facilitate the drug development process and translational research; 5. Advance clinical research. Amount: Up to USD $150,000 per year for one or two years. Deadline for Letters of Intent: February 1, 2020; Full application due: April 1, 2020.
     

November 14, 2019
 

  • My Research Funds (Upgrade to MROL and FReD): Second round of consultation workshops. The Division of the Vice President, Research & Innovation (VPRI) in partnership with the Office of the Chief Information Officer is embarking on a project to upgrade and modernize My Research On Line (MROL) and the Funded Research Digest (FReD). The system, which will be called My Research Funds, will provide a streamlined user experience and offer improved tools to aid researchers and administrators in managing research funding at the University of Toronto. My Research Funds is part of the broader U of T Enterprise Modernization Program that aims to transform the core Research, Human Resources, and Finance systems using the latest enterprise software technology. Read more.  The VPRI is hosting a second round of consultation workshops that are open to all users of MROL and FReD. We encourage you to register for one of the sessions listed below. Instructions on how to register can also be found here.
    University of Toronto St. George Campus
    •    Mon, Nov. 25 | 2:00 pm – 3:00 pm | Sidney Smith Hall Rm 2116
    •    Wed, Nov. 27 | 11:00 am – 12:00 pm | Robarts Library Rm 14190
    •    Thu,  Nov. 28 | 2:00 pm – 3:00 pm | McMurrich Building Rm 107
    •    Mon, Dec. 2 | 2:00 pm – 3:00 pm | McMurrich Building Rm 107
    •    Fri, Dec. 6 | 11:00 am – 12:00 pm | Factor Inwentash School Of Social Work Rm 418
    University of Toronto Scarborough Campus
    •    Thu, Nov. 28 | 10:00 am – 11:00 am | Catalyst Centre Rm EV151/152
    University of Toronto Mississauga Campus
    •    Wed, Dec. 4 | 1:00 pm – 2:00 pm | Maanjiwe nendamowinan Rm 6128
     
  • Can-GARD: Clinical and Research Fellowship in Advanced Genomics in Paediatric Rare Disease. The Canadian Gene Cure Advanced Therapies for Rare Disease (Can-GARD) project and the Centre for Genetic Medicine (CGM), with support from the Division of Clinical and Metabolic Genetics at The Hospital for Sick Children (SickKids). As an emerging area in paediatrics, this clinical research genomics fellowship offers clinicians the opportunity to pursue independent research and clinical work in partnership with a wide range of professionals to enhance children’s health and well-being. This one-year training position begins on July 13, 2020. Application deadline: January 15, 2020.
     
  • 2020 SSHRC Insight Development Grant Information Session (Hosted by Research Services, UofT). The session will cover eligibility requirements, evaluation criteria, proposal development and the submission process (both internal through MRA, and external to SSHRC). A 2019 IDG selection committee member will discuss the adjudication process and elements of a strong proposal. 
    Date: Tuesday, January 7, 2020 from 10am - 11:30am
    Location: The Governing Council Chamber, Simcoe Hall (room 214, second floor), 27 King’s College Circle, St. George campus.
    RSVP to mark.bold@utoronto.ca.
     
  • CIHR: Catalyst Grant - Impacts of financial and organizational restructuring of public health. This opportunity aims to catalyze the foundational scientific work that is necessary to understand the impacts of changes to public health systems across Canada. These catalyst grants, up to $200,000 each, can also fund the development of approaches, methods, models and tools that will enable researchers to examine future changes as well. CIHR hopes to spark new ideas and efforts that will build to larger projects that can be supported through CIHR Project Grants or other funding sources. Registration deadline: December 3, 2019; Application deadline: January 7, 2020.
     
  • IN-PART- The Medical Discovery Catapult (MDC): Industry Call for Opportunities. IN-PART services has an online matchmaking platform for university-industry collaboration. One of their services is to identify opportunities which they think would be of interest to their industry clients. The Medicine Discovery Catapult, a consortium of charities and pharmaceutical companies (also known as the “Psychiatry Consortium”)  has a call for proposals for novel targets for the treatment of psychiatric diseases. The Psychiatry Consortium wishes to fund research focusing on novel molecular targets, pathways and potential therapeutics for mental health conditions. The Psychiatry Consortium intends to commission a grant worth between £200k - £1M to each successful research proposal through a sponsored research agreement. For more information regarding The Psychiatry Consortium specific interests, as well as the application form (which includes more specific information regarding IP rights) please follow the links to the documents below:
    •    Seeking Novel Targets for the Treatment of Psychiatric Diseases
    •    Application form and T&Cs
    Deadline for applications: November 22, 2019
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcements. For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • American Brain Tumor Association. Deadline for Letters of Intent: December 4, 2019.
    • Basic Research Fellowships. These are two-year, $100,000 USD mentored grants supporting postdoctoral fellows who are conducting laboratory or field-based research projects that focus on brain tumors.
    • Discovery Grants: These are one-year, $50,000 USD grants for high risk, high impact research with the potential to change current diagnostic or treatment models.
       
  • Parkinson's Foundation: Clinical Research Award. The Parkinson's Foundation is sponsoring a research award intended to facilitate the development of clinician scientists. This two-year award supports the research expenses of a clinician scientist whose clinically oriented research involves people living with Parkinson's disease. Amount: Up to USD $200,000 total over two years. Deadline for Letters of Intent: January 21, 2019. Full application due April 6, 2020.
     
  • American Institute for Cancer Research: Research Grants. The Investigator-Initiated Research Grant Program welcomes proposals for research addressing the effects of diet, nutrition, body composition, and physical activity on cancer risk and outcomes. Applications to the Investigator-Initiated Grant Program must address either the Cancer Prevention or the Cancer Survivors Research Area and align with at least one of the Research Themes (Biological Mechanisms or Host Factors/Susceptibility); for research in the area of Cancer Survivors, applications are invited to address a third theme of Exposure-Outcome Relationships. Matching grants follow the same eligibility requirements as Investigator-Initiated Research Grants. AICR is interested in working with for-profit corporations and/or non-profit organizations in funding cancer research consistent with AICR's areas of interest. Individual grants offer a maximum funding of USD $150,000 over two years. A limited number of three-year term Investigator-Initiated Research Grants (maximum of USD $225,000 may be funded. Deadline for Letters of Intent: January 24, 2020: Full application deadline: May 15, 2020.
     
  • National Psoriasis Foundation(NPF): Research Grants Program. Deadline for applications: January 13, 2020.
    • Translational Research Grants. Applications related to all aspects of psoriatic disease are strongly encouraged, including basic science, translational research, technology, epidemiology, health services, and clinical research. Amount: Up to USD $100,000 per year.
    • Discovery Grants. Discovery Grants fund researchers while they explore preliminary ideas and conduct proof-of concept experiments. Amount: Up to USD $75,000 per year.
    • Early Career Research Grants. The NPF is seeking grant applications from graduate students, postdoctoral researchers, and researchers at similar trainee-level positions interested in conducting projects focused on psoriatic disease. Amount: Up to USD $50,000.
    • Milestones to a Cure Research Grant. The NPF is seeking grant applications from postdoctoral researchers interested in conducting projects focused on psoriatic disease. The goal of this award is to support research with an aim focused on treatment durability, remission/relapse, prevention and personalized medicine. Amount: Up to USD $100,000 for one year.
  • Pulmonary Fibrosis Foundation. Albert Rose Established Investigator Awards. This award provides critical support to the development of new projects, and enables the investigator to pursue additional funding through the National Institutes of Health or other agencies. Two USD $50,000 grants are awarded per annual cycle, disbursed over a two-year period. Deadline for Letters of Intent: November 22, 2019; Full proposals due: February 9, 2020.
     
  • Society of Surgical Oncology (SSO): Clinical Investigator Award. The purpose of this award is to promote patient-oriented research conducted by surgical oncologists in clinical and translational science. The Foundation requests a proposal in which the applicant plays a central role in the conduct of a specific clinical research project. Applicants must be surgical oncologists within 8 years of completion of training and full SSO members for at least 6 months prior to application submission to be eligible for the award. Amount: USD $100,000 over two years. Deadline for applications: January 7, 2020.

October 30, 2019
 

  • CIHR - New Grants and Awards Guide available November 15, 2019  The CIHR Grants and Awards Guide has been redesigned and CIHR is preparing to launch the new Application Administration Guide on November 15, 2019.
    Key Highlights of the New Guide. CIHR has scheduled webinars to support the research community with the New Guide; the times and dates outlined below:
    ENGLISH: 
    Friday, November 15, 2019 from 12pm - 1pm ET register here
    Thursday, November 21, 2019 from 12:00pm - 1pm ET register here
    FRENCH:
    Monday, November 18, 2019 from 12pm - 1pm ET register here
    Friday, November 22, 2019 from 12pm - 1pm ET register here
     
  • TR Talks - Nov 5th, 2019: Funding Translation 5-7pm. Hosted by the Translational Research Program, University of Toronto. Funding high-impact initiatives based on measurable impacts on health outcomes to create value, the spread and scale-up of promising innovations and sustain successful inventiveness seems like an obvious innovation strategy.  What are the barriers to funding systematic translational research and how can we develop mechanisms that support systematic and value-driven translational?
    Moderator: Salvatore Spadafora; Vice Dean of Post MD Education
    Panelists: David Naylor; Professor of Medicine and President Emeritus at the University of Toronto and Milos R. Popovic; Institute Director of KITE – University Health Network
    Location: Auditorium, 263 McCaul St., Toronto. RSVP here.
     
  • Science2Startup: Call for Proposals, an Event to Foster Therapeutic Startups co-organized by Atlas / F-prime / OUP / RA Capital. S2S is an invitation-only symposium for top scientists from leading research institutions to present their startup ideas and interact with leading investors and executives in the Boston biotechnology hub. 200+ anticipated attendees include entrepreneurs, biotech investors (Angels / VCs), pharma scouts, academic investigators, TTOs, etc. The symposium is a setting to showcase research from selected scientists. Submissions are reviewed by a senior Advisory Group. TTOs are also encouraged to submit 1-page proposals on behalf of researchers. Deadline for proposals: November 1, 2019.
     
  • SickKids: Can-GARD: Advanced Therapies for Rare Diseases - 2020 Spring Accelerator Grant Program. The competition is now open for Letter of Intent (LOI) submission (Deadline: Friday, November 30, 2019 at 11:59 PM, EST.)
    Can-GARD aims to fund proposals that would eliminate barriers in the diagnostic or treatment journey for rare disease patients.  It is anticipated that approximately 3 grants will be awarded in this competition. Any topic: Basic research, clinical application, population studies, and machine learning approaches will be considered. The maximum amount per grant is $75,000CDN per year over a one or two year period, depending upon scope and quality.
    Can-GARD has partnered with The Rare Disease Models and Mechanisms (RDMM) Network who will match one grant* which will be made to an RDMM investigator, aiming to take their research on rare disease diagnosis or treatment to the next level. *RDMM/Can-GARD Connect Award – One of the total awards will be supplemented by the RDMM Network.  Maximum amount of this joint award will be $100,000 CDN per year. Full grant proposals: Due April 1, 2020 (11:59pm, EST).
     
  • Mitacs Elevate - Postdoc Funding Call for applications. Mitacs Elevate is a postdoctoral fellowship with a customized research management training component: Fellows address complex challenges through: 
    -  An exclusive research management curriculum for postdoctoral fellows in any discipline
    -  A minimum one-year research project (normally two years in duration) with a partner organization in need of high-level expertise
    -  A Partner Organization Business Case, developed to outline project objectives, risks, and stakeholder success criteria, and ensure project value
    Full details here. Deadline for Intent to apply (non-mandatory) and Conflict of Interest Declaration (if applicable): January 8, 2020. UofT internal application deadline: February 12, 2020; Mitacs deadline: February 19, 2020.
     
  • Mitacs - Japan Society for the Promotion of Science (JSPS). Mitacs is now accepting applications for the Mitacs-JSPS Summer Program, which supports researchers in Canada to undertake 10-week research projects in Japan in Summer 2020. The program is open to graduate students and postdoctoral fellows in all disciplines at Canadian academic institutions. UofT internal deadline: Nov 20, 2019; Sponsor deadline: Nov 27, 2019. For detailed program and application information, please visit here
     
  • Crohn's and Colitis Canada:
    • Grants-in-Aid of Research. The objective of the Grants-in-Aid of Research is to support research on inflammatory bowel disease (IBD); advance prevention, treatments and health policy; and ultimately find cures. The grant supports research projects conducted by an investigator working alone, or in collaboration with others. Amount: Up to $125,000 for up to three years. Deadline for Notice of Intent: November 22, 2019; Application deadline: January 17, 2020.
    • Innovations in IBD Research. The objective is to fund novel or innovative approaches to IBD research. This grant is intended to stimulate and support research which may not be encompassed within the boundaries of traditional medical research. Research proposals must conform to sound principles of research and may aim to collect pilot data for follow-on application(s). Amount: Up to $50,000 for one year. Application deadline: January 17, 2020. 
       
  • Centre for Research and Applications in Fluidic Technologies (CRAFT) and the National Research Council: CRAFT Fellowships. CRAFT encourages creativity, risk-taking and excellence at the convergence of science, medicine and engineering. Scholarships to support an extensive range of CRAFT research initiatives. CRAFT will invest in bold ideas to enable high-risk, high-reward research projects to be initiated and supported.  Eligible trainees are graduate students preferably enrolled in a Ph.D. program or enrolled in a fast track M.A,Sc program with the potential to transferring into the Ph.D. program. Grant Value: salary support for $12,500/year to be matched by Supervisor/NSERC/CIHR/Other plus $5,000 in support of research endeavours. Duration: term is for 1 year, typically September 1st to August 31st. For the 2020 calendar year, the term is 8 months from January 1st to August 31st, 2020. Deadline for submissions: November 15, 2019.
     
  • National Multiple Sclerosis Society: Pilot Research Grants. The objective of the Pilot Research Grant is to support high-risk research, test innovative cutting-edge ideas or untested methods, and to gather sufficient preliminary data to apply for longer-term funding. Amount: USD $50,000 for one year. Deadline for pre-applications: January 6, 2020; Application deadline: January 8, 2020.
     
  • Cancer Research Institute: Lloyd J. Old STAR Program - Scientists TAking Risks. This program will provide long-term funding to mid-career scientists, providing them a degree of freedom and flexibility to pursue high-risk, high-reward research at the forefront of discovery and innovation. These new grants will not be tied to a specific research project, but rather will support outstanding researchers based on the quality and promise of their overall work. A successful candidate is one that will demonstrate confidence and curiosity to ask difficult immunological questions—forging new understandings and innovation that will drive the field forward. Candidates selected for this award are expected to be future “stars” in the field of cancer immunology. Amount: Up to USD $1.25 million over 5 years to mid-career scientists. Application deadline: January 15, 2020.
     
  • The Michael J. Fox Foundation, ASAP Collaborative Research Network: Aligning Science Across Parkinson's (ASAP) Initiative. This initiative seeks to support international, multidisciplinary, multi-institutional research teams to address key knowledge gaps in the basic disease mechanisms that contribute to Parkinson’s development and progression. The goal is to establish “research hubs” around priority areas with teams comprising the best researcher expertise to address key knowledge gaps, regardless of their geographical location or institutional affiliation. This program solely funds basic research aimed at understanding the 1) structure and function of the nervous system (and related physiological systems) and 2) disease mechanisms that contribute to Parkinson’s disease. Research can involve studies performed in vitro, in animals or in humans. The specific priority areas for this RFA are: Biology of Parkinson's-associated Genes; and Neuro-immune Interactions. 
    Informational WEBINAR: November 14, 2019 at 12pm ET. Register here
    Deadline for pre-proposals: January 8, 2020; Deadline for full proposals (by invite only): April 15, 2020.
     
  • Biocodex Microbiota Foundation (France): International Call for Proposals. The  Foundation funds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The annual grant is set at €200,000 VAT included, independently of the duration of the project (between 1 and 3 years). Application deadline: November 30, 2019.
     
  • Children's Tumor Foundation: Young Investigator Award (YIA): This award provides funding for two years to early-career neurofibromatoses (NF) researchers, helping them to get established as independent investigators. The main function of the YIA program is to serve as a 'seeding mechanism' for researchers to secure larger grants, such as from the NIH and CDMRP NFRP. The YIA mechanism supports basic and translational research towards understanding cellular, genetic, and molecular mechanisms underlying the pathogenesis of NF; Identifying novel therapeutic targets; Testing novel therapeutic targets; Testing candidate therapeutics; and Analysis of natural history of NF. Amount: Up to USD 108,000 for two years. Deadline for Letters of Intent: January 3, 2020; Application deadline: March 6, 2020.
     
  • American Association for Cancer Research (AACR):
    • AACR-PLGA Fund at the Pediatric Brain Tumor Foundation Research Grant to Optimize Drug Dosing Strategies for Pediatric LGA/LGG Patients. This grant represents a joint effort to promote and support innovative and collaborative research focused on the most common forms of pediatric brain cancer - low grade glioma/astrocytoma. The research proposed for funding should be translational in nature (though basic science and clinical proposals will also be considered), and should be focused on improving the understanding and identification of effective dosing parameters for treating children with PLGA brain tumors, with indications for children battling other types of brain tumors. Proposals should also include at least one collaborator from an institution separate from the applicant's institution. Amount: Up to USD $180,000 over two years. Deadline for applications: December 9, 2020.
    • The AACR Gertrude B. Elion Cancer Research Award represents a joint effort to encourage and support tenure-eligible junior faculty. The research proposed for funding must focus on research in cancer etiology, diagnosis, treatment, or prevention and may be basic, translational, or clinical in nature. Amount: USD $75,000 for one year. Deadline for applications: November 21, 2019.
    • AACR-Bristol-Myers Squibb Midcareer Female Investigator Grant represents a joint effort to encourage and support mid-career female physician-scientists and researchers to conduct immuno-oncology research and to foster their career advancement toward becoming a senior investigator. Research projects may be translational and/or clinical in nature with a focus on immuno-oncology. Amount: USD $225,000 ove three years. Deadline for applications: November 19, 2019.
    • AACR-Novocure Tumor Treating Fields Research Grants represent a joint effort to promote and support independent investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells). Amount: USD $225,000 over three years. Deadline for applications: December 11, 2019.
    • AACR-Novocure Career Development Awards for Tumor Treating Fields Research represent a joint effort to promote and support early-career investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells). Amount: USD $225,000 over three years. Deadline for applications: December 11, 2019.
    • Breast Cancer Research Foundation-AACR Career Development Awards for Translational Breast Cancer Research represent a joint effort to promote and support innovative research designed to accelerate the discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent. Amount: USD $150,000 over two years. Deadline for applications: December 18, 2019.
    • Neuroendocrine Tumor Research Foundation-AACR Grant represents a joint effort to promote and support innovative cancer research. This grant is available to independent junior and senior investigators to develop and study new ideas and innovative approaches that have direct application and relevance to neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, or clinical cancer research. Amount: USD $250,000 over two years. Deadline for applications: January 7, 2020.
       
  • Marsha Rivkin Center for Ovarian Cancer Research: Pilot Study Awards. Funding is open to investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered. Amount: Up to USD $75,000 over two years. Deadline for applications: December 2, 2019.
     
  • American Society for Gastrointestinal Endoscopy (ASGE): ASGE Endoscopic Research Awards. The ASGE is particularly interested in research pertaining to (in no particular order): colorectal cancer screening, Barrett's esophagus, endoscopy training, health disparities, quality measurement and improvement, endoscope reprocessing and infection control, endoscopic sedation/anesthesia, bowel preparation, novel endoscopic treatments for obesity, endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), and other endoscopically-guided imaging/interventions. Amount: Up to USD $75,000 for up to two years. Deadline for applications: December 13, 2019.
     
  • Society for Pediatric Dermatology (SPD): Research Grants. The SPD and its research arm, the Pediatric Dermatology Research Alliance (PeDRA), are committed to boosting pediatric research in spite of hurdles and inherent difficulties related to funding research involving both rare and common diseases in young children. Amount: Up to USD $15,000 for one year to support early stage research, with the opportunity to renew.  Deadline for applications: December 12, 2019.

 

October 17, 2019
 

  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcements. For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.